Tumor shrinkage by cyclopamine tartrate through inhibiting hedgehog signaling

Qipeng Fan, Dongsheng Gu, Miao He, Hailan Liu, Tao Sheng, Guorui Xie, Ching Xin Li, Xiaoli Zhang, Brandon Wainwright, Arash Garrossian, Massoud Garrossian, Dale Gardner, Jingwu Xie

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The link of hedgehog (Hh) signaling activation to human cancer and synthesis of a variety of Hh signaling inhibitors raise great expectation that inhibiting Hh signaling may be effective in human cancer treatment. Cyclopamine (Cyc), an alkaloid from the Veratrum plant, is a specific natural product inhibitor of the Hh pathway that acts by targeting smoothened (SMO) protein. However, its poor solubility, acid sensitivity, and weak potency relative to other Hh antagonists prevent the clinical development of Cyc as a therapeutic agent. Here, we report properties of cyclopamine tartrate salt (CycT) and its activities in Hh signaling-mediated cancer in vitro and in vivo. Unlike Cyc, CycT is water soluble (5-10 mg/mL). The median lethal dose (LD50) of CycT was 62.5 mg/kg body weight compared to 43.5 mg/kg for Cyc, and the plasma half-life (T1/2) of CycT was not significantly different from that of Cyc. We showed that CycT had a higher inhibitory activity for Hh signaling-dependent motor neuron differentiation than did Cyc (IC50 = 50 nmol/L for CycT vs. 300 nmol/L for Cyc). We also tested the antitumor effectiveness of these Hh inhibitors using two mouse models of basal cell carcinomas (K14cre:Ptch1neo/neo and K14cre:SmoM2YFP). After topical application of CycT or Cyc daily for 21 days, we found that all CycT-treated mice had tumor shrinkage and decreased expression of Hh target genes. Taken together, we found that CycT is an effective inhibitor of Hh signaling-mediated carcinogenesis.

Original languageEnglish
Pages (from-to)472-481
Number of pages10
JournalChinese Journal of Cancer
Volume30
Issue number7
DOIs
StatePublished - 2011

Fingerprint

Hedgehogs
Neoplasms
Salts
cyclopamine
tartaric acid
Veratrum Alkaloids
Basal Cell Carcinoma
Lethal Dose 50
Motor Neurons
Biological Products

Keywords

  • Cancer therapy
  • Cyclopamine tartrate
  • Hedgehog
  • Mouse model
  • Smoothened

ASJC Scopus subject areas

  • Oncology

Cite this

Tumor shrinkage by cyclopamine tartrate through inhibiting hedgehog signaling. / Fan, Qipeng; Gu, Dongsheng; He, Miao; Liu, Hailan; Sheng, Tao; Xie, Guorui; Li, Ching Xin; Zhang, Xiaoli; Wainwright, Brandon; Garrossian, Arash; Garrossian, Massoud; Gardner, Dale; Xie, Jingwu.

In: Chinese Journal of Cancer, Vol. 30, No. 7, 2011, p. 472-481.

Research output: Contribution to journalArticle

Fan, Q, Gu, D, He, M, Liu, H, Sheng, T, Xie, G, Li, CX, Zhang, X, Wainwright, B, Garrossian, A, Garrossian, M, Gardner, D & Xie, J 2011, 'Tumor shrinkage by cyclopamine tartrate through inhibiting hedgehog signaling', Chinese Journal of Cancer, vol. 30, no. 7, pp. 472-481. https://doi.org/10.5732/cjc.011.10157
Fan, Qipeng ; Gu, Dongsheng ; He, Miao ; Liu, Hailan ; Sheng, Tao ; Xie, Guorui ; Li, Ching Xin ; Zhang, Xiaoli ; Wainwright, Brandon ; Garrossian, Arash ; Garrossian, Massoud ; Gardner, Dale ; Xie, Jingwu. / Tumor shrinkage by cyclopamine tartrate through inhibiting hedgehog signaling. In: Chinese Journal of Cancer. 2011 ; Vol. 30, No. 7. pp. 472-481.
@article{b5309104c22c406381e6f10de956382b,
title = "Tumor shrinkage by cyclopamine tartrate through inhibiting hedgehog signaling",
abstract = "The link of hedgehog (Hh) signaling activation to human cancer and synthesis of a variety of Hh signaling inhibitors raise great expectation that inhibiting Hh signaling may be effective in human cancer treatment. Cyclopamine (Cyc), an alkaloid from the Veratrum plant, is a specific natural product inhibitor of the Hh pathway that acts by targeting smoothened (SMO) protein. However, its poor solubility, acid sensitivity, and weak potency relative to other Hh antagonists prevent the clinical development of Cyc as a therapeutic agent. Here, we report properties of cyclopamine tartrate salt (CycT) and its activities in Hh signaling-mediated cancer in vitro and in vivo. Unlike Cyc, CycT is water soluble (5-10 mg/mL). The median lethal dose (LD50) of CycT was 62.5 mg/kg body weight compared to 43.5 mg/kg for Cyc, and the plasma half-life (T1/2) of CycT was not significantly different from that of Cyc. We showed that CycT had a higher inhibitory activity for Hh signaling-dependent motor neuron differentiation than did Cyc (IC50 = 50 nmol/L for CycT vs. 300 nmol/L for Cyc). We also tested the antitumor effectiveness of these Hh inhibitors using two mouse models of basal cell carcinomas (K14cre:Ptch1neo/neo and K14cre:SmoM2YFP). After topical application of CycT or Cyc daily for 21 days, we found that all CycT-treated mice had tumor shrinkage and decreased expression of Hh target genes. Taken together, we found that CycT is an effective inhibitor of Hh signaling-mediated carcinogenesis.",
keywords = "Cancer therapy, Cyclopamine tartrate, Hedgehog, Mouse model, Smoothened",
author = "Qipeng Fan and Dongsheng Gu and Miao He and Hailan Liu and Tao Sheng and Guorui Xie and Li, {Ching Xin} and Xiaoli Zhang and Brandon Wainwright and Arash Garrossian and Massoud Garrossian and Dale Gardner and Jingwu Xie",
year = "2011",
doi = "10.5732/cjc.011.10157",
language = "English",
volume = "30",
pages = "472--481",
journal = "Cancer Communications",
issn = "1000-467X",
publisher = "BioMed Central Ltd.",
number = "7",

}

TY - JOUR

T1 - Tumor shrinkage by cyclopamine tartrate through inhibiting hedgehog signaling

AU - Fan, Qipeng

AU - Gu, Dongsheng

AU - He, Miao

AU - Liu, Hailan

AU - Sheng, Tao

AU - Xie, Guorui

AU - Li, Ching Xin

AU - Zhang, Xiaoli

AU - Wainwright, Brandon

AU - Garrossian, Arash

AU - Garrossian, Massoud

AU - Gardner, Dale

AU - Xie, Jingwu

PY - 2011

Y1 - 2011

N2 - The link of hedgehog (Hh) signaling activation to human cancer and synthesis of a variety of Hh signaling inhibitors raise great expectation that inhibiting Hh signaling may be effective in human cancer treatment. Cyclopamine (Cyc), an alkaloid from the Veratrum plant, is a specific natural product inhibitor of the Hh pathway that acts by targeting smoothened (SMO) protein. However, its poor solubility, acid sensitivity, and weak potency relative to other Hh antagonists prevent the clinical development of Cyc as a therapeutic agent. Here, we report properties of cyclopamine tartrate salt (CycT) and its activities in Hh signaling-mediated cancer in vitro and in vivo. Unlike Cyc, CycT is water soluble (5-10 mg/mL). The median lethal dose (LD50) of CycT was 62.5 mg/kg body weight compared to 43.5 mg/kg for Cyc, and the plasma half-life (T1/2) of CycT was not significantly different from that of Cyc. We showed that CycT had a higher inhibitory activity for Hh signaling-dependent motor neuron differentiation than did Cyc (IC50 = 50 nmol/L for CycT vs. 300 nmol/L for Cyc). We also tested the antitumor effectiveness of these Hh inhibitors using two mouse models of basal cell carcinomas (K14cre:Ptch1neo/neo and K14cre:SmoM2YFP). After topical application of CycT or Cyc daily for 21 days, we found that all CycT-treated mice had tumor shrinkage and decreased expression of Hh target genes. Taken together, we found that CycT is an effective inhibitor of Hh signaling-mediated carcinogenesis.

AB - The link of hedgehog (Hh) signaling activation to human cancer and synthesis of a variety of Hh signaling inhibitors raise great expectation that inhibiting Hh signaling may be effective in human cancer treatment. Cyclopamine (Cyc), an alkaloid from the Veratrum plant, is a specific natural product inhibitor of the Hh pathway that acts by targeting smoothened (SMO) protein. However, its poor solubility, acid sensitivity, and weak potency relative to other Hh antagonists prevent the clinical development of Cyc as a therapeutic agent. Here, we report properties of cyclopamine tartrate salt (CycT) and its activities in Hh signaling-mediated cancer in vitro and in vivo. Unlike Cyc, CycT is water soluble (5-10 mg/mL). The median lethal dose (LD50) of CycT was 62.5 mg/kg body weight compared to 43.5 mg/kg for Cyc, and the plasma half-life (T1/2) of CycT was not significantly different from that of Cyc. We showed that CycT had a higher inhibitory activity for Hh signaling-dependent motor neuron differentiation than did Cyc (IC50 = 50 nmol/L for CycT vs. 300 nmol/L for Cyc). We also tested the antitumor effectiveness of these Hh inhibitors using two mouse models of basal cell carcinomas (K14cre:Ptch1neo/neo and K14cre:SmoM2YFP). After topical application of CycT or Cyc daily for 21 days, we found that all CycT-treated mice had tumor shrinkage and decreased expression of Hh target genes. Taken together, we found that CycT is an effective inhibitor of Hh signaling-mediated carcinogenesis.

KW - Cancer therapy

KW - Cyclopamine tartrate

KW - Hedgehog

KW - Mouse model

KW - Smoothened

UR - http://www.scopus.com/inward/record.url?scp=79960498438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960498438&partnerID=8YFLogxK

U2 - 10.5732/cjc.011.10157

DO - 10.5732/cjc.011.10157

M3 - Article

VL - 30

SP - 472

EP - 481

JO - Cancer Communications

JF - Cancer Communications

SN - 1000-467X

IS - 7

ER -